Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling

Chuanhui Han1, Zhida Liu1, Yunjia Zhang2

  • 1Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.

Nature Immunology
|April 2, 2020
PubMed

Insights

High-dose radiation triggers tumor cells to suppress intrinsic DNA sensing via caspase 9 signaling, using mitochondrial DNA instead of apoptotic DNA. Combining radiation with caspase inhibitors and anti-PD-L1 therapy overcomes tumor resistance.

Area of Science:

  • Cancer biology
  • Immunology
  • Radiation oncology

Background:

  • High-dose radiation therapy generates DNA fragments that activate antigen-presenting cells but has limited intrinsic DNA sensing in tumor cells.
  • Tumor cells can suppress their own intrinsic DNA sensing mechanisms following radiation exposure.

Purpose of the Study:

  • To investigate how irradiated tumor cells suppress intrinsic DNA sensing.
  • To explore the role of caspase 9 signaling in this process.
  • To evaluate therapeutic strategies combining radiation with caspase inhibitors and immune checkpoint blockade.

Main Methods:

  • Analysis of caspase 9 signaling in irradiated tumor cells.
  • Investigation of DNA sensing pathways, distinguishing between apoptotic and mitochondrial DNA.
  • Assessment of therapeutic effects of radiation, emricasan (pan-caspase inhibitor), and anti-PD-L1 blockade in preclinical models.
  • Evaluation of programmed death-ligand 1 (PD-L1) expression and its role in adaptive resistance.

Main Results:

  • Irradiated tumor cells hijack caspase 9 signaling to suppress intrinsic DNA sensing, utilizing tumor-derived mitochondrial DNA.
  • Loss of caspase 9 or mitochondrial DNA sensing in tumors abrogates the enhanced therapeutic effect of radiation.
  • Combining radiation with emricasan demonstrates synergistic therapeutic effects.
  • Loss of caspase 9 signaling induces adaptive resistance via PD-L1 upregulation, leading to tumor relapse.
  • Combined blockade of caspase 9 and PD-L1 signaling effectively controls tumors.

Conclusions:

  • Caspase 9 signaling is a critical regulator of intrinsic DNA sensing in irradiated tumor cells, with mitochondrial DNA playing a key role.
  • Targeting caspase 9 with inhibitors and combining with radiation and anti-PD-L1 therapy offers a promising strategy to overcome tumor resistance and enhance treatment efficacy.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K